Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06259526
What this trial is testing

The Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression

Who this might be right for
Depression
Tasly Pharmaceutical Group Co., Ltd 267
Testing effectiveness (Phase 2)Ended earlyNCT06516926
What this trial is testing

SHR-4602 for Injection in Subjects With HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors

Who this might be right for
HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors
Jiangsu HengRui Medicine Co., Ltd. 11
Testing effectiveness (Phase 2)Looking for participantsNCT07154264
What this trial is testing

DZD8586 Combination in CLL/SLL (TAI-SHAN10)

Who this might be right for
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Dizal Pharmaceuticals 66
Testing effectiveness (Phase 2)Study completedNCT01037998
What this trial is testing

UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
Taipei Veterans General Hospital, Taiwan 115
Testing effectiveness (Phase 2)Ended earlyNCT04542993
What this trial is testing

Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy

Who this might be right for
Covid19SARS-CoV Infection
Swedish Medical Center 45
Testing effectiveness (Phase 2)Study completedNCT00068393
What this trial is testing

Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell CarcinomaRenal Cell Carcinoma With Sarcomatoid Features
Eastern Cooperative Oncology Group 39
Testing effectiveness (Phase 2)Study completedNCT01957306
What this trial is testing

Safety and Efficacy of Dr. Tagliaferri's Menopause Formula

Who this might be right for
Hot Flashes
Herba Buena, Inc 30
Testing effectiveness (Phase 2)UnknownNCT04827004
What this trial is testing

Anlotinib Hydrochloride Capsules in Subjects With Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT00126984
What this trial is testing

Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 508
Testing effectiveness (Phase 2)Looking for participantsNCT05668884
What this trial is testing

GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma

Who this might be right for
Biliary Tract Carcinoma
Fudan University 93
Testing effectiveness (Phase 2)Study completedNCT00072852
What this trial is testing

Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine

Who this might be right for
Breast Neoplasms
Pfizer 134
Testing effectiveness (Phase 2)UnknownNCT03173638
What this trial is testing

Safety Assessment of Intravitreal Mesenchymal Stem Cells for Acute Non Arteritic Anterior Ischemic Optic Neuropathy

Who this might be right for
Non Arteritic Ischemic Optic Neuropathy
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA 5
Testing effectiveness (Phase 2)Ended earlyNCT02378038
What this trial is testing

PNT2258 for Treatment of Patients With Richter's Transformation (Brighton)

Who this might be right for
Richter's Transformation
Sierra Oncology LLC - a GSK company 5
Testing effectiveness (Phase 2)Study completedNCT01956058
What this trial is testing

Brachytherapy for Recurrent Prostate Cancer

Who this might be right for
Recurrent Prostate CancerBrachytherapy Remedial
Centre Georges Francois Leclerc 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06465238
What this trial is testing

Clinical Study of SHR-A1921 or SHR-A2009 in Previously Treated Advanced NSCLC

Who this might be right for
NSCLC
Henan Cancer Hospital 30
Not applicableNot Yet RecruitingNCT07421648
What this trial is testing

BandPass: A Remote Monitoring System for Sarcopenia and Functional Decline Phase II Aim 4

Who this might be right for
SarcopeniaFrailty
SynchroHealth LLC 39
Testing effectiveness (Phase 2)Study completedNCT00230126
What this trial is testing

OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Ohio State University Comprehensive Cancer Center 57
Large-scale testing (Phase 3)Active Not RecruitingNCT04208178
What this trial is testing

Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation

Who this might be right for
Advanced HER2+Breast Cancer
Novartis Pharmaceuticals 19
Testing effectiveness (Phase 2)Study completedNCT00000626
What this trial is testing

Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease

Who this might be right for
HIV InfectionsHodgkin's Disease
National Institute of Allergy and Infectious Diseases (NIAID) 27
Testing effectiveness (Phase 2)WithdrawnNCT02011126
What this trial is testing

Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
HepatoblastomaPreviously Treated Childhood RhabdomyosarcomaRecurrent Childhood Liver Cancer+5 more
Children's Oncology Group
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation